Chester County News and Community Website
WASHINGTON, D.C. — The Food and Drug Administration (FDA) has announced that the national supply of cisplatin, a key cancer medication, now exceeds demand, ending a critical shortage that began …
FDA Announces End to National Shortage of Crucial Cancer Drug Cisplatin Read More
WASHINGTON, D.C. — The Food and Drug Administration (FDA) recently granted accelerated approval to Epkinly (epcoritamab-bysp), a new treatment option for adults with relapsed or refractory follicular lymphoma (FL). This …
FDA Grants Accelerated Approval to New Treatment for Relapsed Follicular Lymphoma Read More
WASHINGTON, D.C. — The Food and Drug Administration (FDA) recently granted accelerated approval for a new treatment combination for adults with KRAS G12C-mutated locally advanced or metastatic colorectal cancer (CRC). …
FDA Grants Accelerated Approval to New Colorectal Cancer Treatment Read More
SUZHOU, China and NEWTOWN SQUARE, PA — ArriVent BioPharma, Inc. announced a strategic collaboration with Jiangsu Alphamab Biopharmaceuticals Co., Ltd. (“Alphamab”) to develop and commercialize novel antibody drug conjugates (ADCs) …
ArriVent BioPharma Partners with Alphamab to Develop Cutting-Edge Cancer Treatments Read More